FMOD and cancer: We find that FMOD activates ERK to promote BCCMI, which is reminiscent of hyaluronan mediated motility receptor (RHAMM) promoting BCCMI via activation of ERK (Wang et al., 2014b), and undergoes the important part that ERK plays in cancer metastasis.